Daxor
5 hedge funds and large institutions have $628K invested in Daxor in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
0.17% less ownership
Funds ownership: 1.55% → 1.38% (-0.17%)
9% less capital invested
Capital invested by funds: $690K → $628K (-$62K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$26.1K |
| 2 |
Renaissance Technologies
New York
|
+$2.13K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$32 |
Top Sellers
DXR Hedge Fund Activity: Q2 2023 in Review
5 of the 6,385 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q2 2023, worth a combined $628K — down 9% from $690K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new DXR positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $26.1K.
- 5 institutional investors held Daxor (DXR) as of Q2 2023, up from 4 in Q1 2023.
- Funds reported $628K of Daxor stock for Q2 2023, down 9% quarter-over-quarter.
- 1 fund opened new Daxor positions in Q2 2023 and 0 closed out, a net change of +1 holder.
- The largest Daxor buyer in Q2 2023 was UBS Group, an estimated $26.1K added.
Based on aggregated 13F filings for Q2 2023.